Pieris Pharmaceuticals Research and Development Expenses 2014-2024 | PVLA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pieris Pharmaceuticals research and development expenses from 2014 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Pieris Pharmaceuticals Research and Development Expenses 2014-2024 | PVLA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pieris Pharmaceuticals research and development expenses from 2014 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
NPK (NPKI)	$626M
Performant Healthcare (PHLT)	$245M
FTAC Emerald Acquisition (FLDD)	$158M
Swiftmerge Acquisition (ANNA)	$42M
Insight Acquisition (AMOD)	$23M
Hanryu Holdings (GITS)	$17M
LQR House (YHC)	$11M
ATIF Holdings (ZBAI)	$9M
Lion Electric (LEVGQ)	$0M